AACR Conferences 2012



GLBs more likely to enroll in cancer trials

HT Staff Read Article
Published: 10/31/12

Worker preparing capsules
for a clinical trial
Credit: Esther Dyson

Results of a new study showed that cancer survivors who self-identified as gay, lesbian, or bisexual (GLB) were more than twice as likely as heterosexual survivors to have participated in clinical trials. These findings run counter to results of previous research, which suggested that GLB and transgendered individuals are medically underserved and underrepresented in all types of clinical trials. Jennifer M. Jabson, MPH, PhD, of the Boston University School of Public Health . . . [Read Article]

Language barriers, immigration status affect cancer care

HT Staff Read Article
Published: 10/31/12

Doctor examining a patient
Credit: Logan Tuttle

Language barriers and the immigration status of caregivers can impact the care of Hispanic children with cancer, results of a single-center study suggest. The research also indicates that these factors affect a family’s overall experience within the medical system. Mark Fluchel, MD, of the University of Utah Primary Children’s Medical Center in Salt Lake City, and his colleagues discussed these issues at the 5th AACR Conference on The Science of Cancer Health Disparities, which took place October 27-30. [Read Article]

Race plays role in clinical trial discussions

HT Staff Read Article
Published: 10/30/12

Doctor speaking with a family
Credit: Rhoda Baer

Results of a small study appear to confirm racial disparities in the quality of communication between physicians and patients. Researchers compared discussions about cancer trials with black patients to cancer trial discussions with white patients. And the team found that oncologists provided black patients with less overall information. Susan Eggly, PhD, of the Wayne State University School of Medicine in Detroit, and her colleagues reported these results at the 5th AACR Conference . . . [Read Article]

Perception of cancer care differs according to race/ethnicity

HT Staff Read Article
Published: 10/29/12

Doctor consulting with a cancer
patient and her father
Credit: Rhoda Baer

Results of a new study indicate that race or ethnicity may impact cancer survivors’ communication with their healthcare providers. And this can influence the survivors’ perceptions of follow-up care. All of the minority groups studied reported poorer communication, in some respect, than non-Hispanic white cancer survivors. But Asian survivors consistently reported poorer communication and a lower quality of follow-up care. These results were presented at the 5th AACR Conference on The Science of Cancer . . . [Read Article]

Infant feeding practices may influence ALL risk

HT Staff Read Article
Published: 10/19/12

Child eating watermelon
Credit: Petr Kratochvil

New research suggests that feeding practices in infancy may be associated with a child’s risk of developing acute lymphoblastic leukemia (ALL). Results of this retrospective, case-control study indicate that feeding infants formula for longer periods and delaying the introduction of solid foods both increase a child’s risk of ALL. However, it appears that time is a key factor, as the researchers did not see a greater risk of ALL in children who only received formula compared to children . . . [Read Article]

Lifestyle choices impact mortality in cancer survivors

HT Staff Read Article
Published: 10/19/12

Retirement community
residents exercising
Credit: Flip Schulke

Adhering to lifestyle guidelines can reduce mortality in postmenopausal female cancer survivors, according to a new study. Investigators found that overall adherence to recommendations for maintaining an ideal body weight, staying physically active, and eating a healthful diet improved survival in these patients.  However, when the researchers assessed guideline recommendations individually, they found that only adherence to physical activity recommendations had a positive impact on . . . [Read Article]

Daily multivitamins can reduce cancer risk in men

HT Staff Read Article
Published: 10/18/12

Pack of multivitamins
Photo courtesy of Brigham
and Women′s Hospital

Results of a long-term, randomized trial suggest that taking a multivitamin can reduce the risk of cancer in men over the age of 50. The trial, which included nearly 15,000 male physicians, showed that long-term daily multivitamin use resulted in a modest but statistically significant reduction in overall cancer incidence. The trial’s results were published online in JAMA and presented at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research on October 17. [Read Article]


    {icon} {author} Read Article
    Published: {pubDate}